Publications by authors named "D Hetuin"

Claim this Profile
R
RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage.
A-L Nugues, H El Bouazzati, D Hétuin, C Berthon, A Loyens

Cell Death Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural explanation of the effects of dissociated glucocorticoids on glucocorticoid receptor transactivation.
Xavier Dezitter, Jérôme Fagart, Solenne Taront, Michel Fay, Bernadette Masselot

Mol Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells.
S Joha, A-L Nugues, D Hétuin, C Berthon, X Dezitter

Oncogene· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.
Céline Berthon, Virginie Driss, Jizhong Liu, Klaudia Kuranda, Xavier Leleu, Dominique Hetuin

Cancer Immunol Immunother· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism.
J Liu, S Joha, T Idziorek, S Corm, D Hetuin

Leukemia· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis